Mitochondrial Dysfunction during Sepsis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 3, 2010-09 ,pp. : 214-223

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomic Analysis of Endothelin-1 Targets in the Regulation of Cardiomyocyte Proliferation

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 15, 2017-04 ,pp. : 1788-1802

Bentham Science Publishers

Access to resources Recommend Favorite

Use of A-192621 to provide evidence for involvement of endothelin ET B -receptors in endothelin-1-mediated cardiomyocyte hypertrophy

By Cullen J.P.   Bell D.   Kelso E.J.   McDermott B.J.  

European Journal of Pharmacology, Vol. 417, Iss. 3, 2001-04 ,pp. : 157-168

Elsevier

Access to resources Recommend Favorite

Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances

By  

Current Molecular Pharmacology, Vol. 10, Iss. 3, 2017-05 ,pp. : 207-225

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-induced mitochondrial dysfunction in cardiac and skeletal muscle injury

By Sardo Vilma A   Pereira Sandro L   Oliveira Paulo J  

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 129-146

Informa Healthcare

Access to resources Recommend Favorite